Nightingale and ExpeData(R) To Launch Innovative EMR-Integrated Digital Pen Technology Solution
21 Februar 2012 - 1:30PM
PR Newswire (Canada)
Clinipen, a game changing pen-based input device, has potential to
accelerate EMR adoption MARKHAM, ON, and LAS VEGAS, NV, Feb. 21,
2012 /CNW/ - Nightingale Informatix Corporation ("Nightingale" or
the "Company", an application service provider (ASP) of Electronic
Medical Record (EMR) software and related services and ExpeData,
LLC ("ExpeData"), an innovative software company and global leader
in digital writing, announced plans to launch "Clinipen", an
EMR-integrated digital writing solution. Clinipen will be available
in Canada in March 2012 and in the United States by August 2012.
Clinipen will enable EMR software providers to deliver an
integrated digital writing solution that healthcare providers can
use to input structured data into a patient's EMR directly from
paper. The solution leverages the EDW® digital writing platform
from ExpeData along with Anoto® digital pen and paper technology
and Vision Objects' industry-leading handwriting recognition
technologies. Nightingale's leading web-based EMR, Nightingale On
Demand, will be the first solution seamlessly integrated with
Clinipen. "Nightingale is committed to innovation and making the
transition from paper records to EMR as seamless as possible for
physicians," said Sam Chebib, President and CEO of Nightingale. "We
believe Clinipen is a major breakthrough in EMR data entry, as it
allows healthcare providers to continue using paper forms to
document patient encounters and write prescriptions. We believe
integrating ExpeData's digital writing technology with Nightingale
On Demand position both companies as clear technology leaders in
the North American EMR market." In Canada, it is estimated that
more than 60% of physicians are still using paper-based
records.(1)A recent independent survey conducted in the US
indicated that only 34% of healthcare providers use a comprehensive
EMR system, while 16% indicated using a partial system. 29% of
respondents indicated that they are evaluating solutions, while 20%
indicated that they have not yet started the adoption process.( 2)
"The seamless integration of the Clinipen digital writing
technology with Nightingale On Demand provides healthcare providers
with a familiar alternative to using a computer to input patient
data into their EMR," said Brandon Major, Vice President and COO,
ExpeData. "Unlike other digital pen products in the market place,
Clinipen leverages the power of templates and intelligent
handwriting recognition to allow users to continue to use paper as
an input method, populating Nightingale's EMR with structured
discrete data. We believe this will make the transition to EMR much
more appealing to a large segment of Canadian and US healthcare
providers." In May 2011, Nightingale and ExpeData announced a
joint venture agreement for exclusive distribution rights for the
Clinipen technology products for the EMR industry in North America.
Each company will maintain 50% ownership. Clinipen is the first
product being launched as a result of the joint venture. ExpeData
and Vision Objects are part of the digital writing investment
portfolio held by Myrian Capital, a private equity firm focused on
emerging technology businesses. "Through this first Clinipen
product, we are removing the obstacles to EMR adoption by making
the solution user-friendly for those healthcare providers who
continue to use handwritten paper-based records," said Paddy
Padmanabhan, CEO of ExpeData and Managing Director of Myrian
Capital. "They can now seamlessly transition to an EMR while
maintaining the same processes across their healthcare
organization. This provides groundbreaking potential to accelerate
EMR adoption." 1. 2009 Commonwealth Fund International Health
Policy Survey of Primary Care Physicians 2. 2nd Annual Healthcare
IT Market: Insights and Opportunities Study, CompTIA, 2010 About
Nightingale Informatix Corporation (http://www.nightingalemd.ca)
Nightingale is one of the fastest growing health care service and
software companies in North America and is recognized as an
industry leader in Web-based clinician and community based
electronic medical records (EMR) and patient portals, serving the
needs of small primary care practices, multi-physician outpatient
clinics, and large scale regional health organizations and
networks. Coupled with integrated practice management,
transcription and revenue cycle management, Nightingale's
comprehensive service offering allows customers to enhance patient
care, increase revenue opportunities and optimize operations.
Nightingale is continuously innovating and enhancing its services
to meet the needs of its growing and diverse customer base.
Nightingale - Healthcare connected. About ExpeData, LLC ExpeData is
an innovative software company and a global leader in natural input
technologies. ExpeData has created an end-to-end software platform
that automates the collection of natural input including
handwriting at the point of entry. Information captured with
tablets or digital pens is immediately converted to digital data
and seamlessly integrated to backend systems.
Straight-through processing eliminates cycle time delays, resulting
in unsurpassed workflow optimization and significant cost savings.
EDW solutions are used across the globe, delivering value in
multiple industries. To learn more, visit http://www.expedata.net.
Featuring Anoto Functionality The EDW® solutions are, in part,
based on Anoto Digital Pen and Paper Technology, which is covered
by over 200 patents worldwide, including but not limited to
US6663008, US7172131, US7248250, US7281668, JP3872498, JP3842283,
CN1595440, SE517445, RU2256225, and AU773011. "Anoto", "Magic Box"
and the Anoto logotype are trademarks owned by Anoto AB. Forward
Looking Statement This press release contains "forward-looking
statements" respecting the issuance and cancellation of securities
of the Company within the meaning of applicable Canadian securities
legislation. Generally, forward-looking statements can be
identified by the use of forward- looking terminology such as
"plans", "expects" or "does not expect", "is expected", "budget",
"scheduled", "estimates", "forecasts", "intends", "anticipates" or
"does not anticipate", or "believes", or variations of such words
and phrases or state that certain actions, events or results "may"
,"could", "would", "might" or "will be taken", "occur" or "be
achieved". Forward-looking statements are subject to known and
unknown risks, uncertainties and other factors that may cause the
actual results, level of activity, performance or achievements of
Nightingale to be materially different from those expressed or
implied by such forward-looking statements, including but not
limited to: risks related to the speculative nature of the medical
software industry, which is affected by numerous factors beyond
Nightingale's control; the ability of Nightingale to successfully
integrate its acquisitions and any liabilities arising as a result
of such acquisitions, access to capital and agreements with its
Lenders; the existence of present and possible future government
regulation; access to debt or equity financing and agreements with
its Lenders; the significant and increasing competition that exists
in the medical software industry; the early stage of Nightingale's
business; and therefore it is subject to the risks associated with
early stage companies, including uncertainty of revenues, markets
and profitability and the need to raise additional funding.
All material assumptions used in making forward-looking statements
are based on management's knowledge of current business conditions
and expectations of future business conditions and trends. Although
management believes the assumptions used to make such statements
are reasonable at this time, our assumptions may not to be as
anticipated, estimated or intended. Certain material factors or
assumptions applied by management in making forward-looking
statements, include without limitation, factors and assumptions
regarding Nightingale's continued ability to fund its business,
rates of customer defaults, relationships with, and payments to,
lenders, demand for Nightingale's products, as well as
Nightingale's operating cost structure. Neither the TSX Venture
Exchange nor its Regulation Services Provider (as that term is
defined in the policies of the TSX Venture Exchange) accepts
responsibility for the adequacy or accuracy of this release.
Nightingale Informatix Corporation CONTACT: Nightingale Media
InquiriesSharmeen ArafatMarketing ManagerT
905.307.3617sarafat@nightingalemd.com Investor InquiriesKristen
Dickson, M.Sc.Equicom, a TMX Group CompanyTel: 416.815.0700 ext.
273kdickson@equicomgroup.comExpeData, LLCApril D'AngeloDirector,
Marketing and Corporate
Communications937-439-6774april.dangelo@expedata.net
Copyright
Nightingale Informatix Corporati (TSXV:NGH)
Historical Stock Chart
Von Jun 2024 bis Jul 2024
Nightingale Informatix Corporati (TSXV:NGH)
Historical Stock Chart
Von Jul 2023 bis Jul 2024